Tirosint patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7691411 INSTITUT BIOCHIMIQUE Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
Mar, 2024

(5 months from now)

US7723390 INSTITUT BIOCHIMIQUE Pharmaceutical formulations for thyroid hormones
Mar, 2024

(5 months from now)

Tirosint is owned by Institut Biochimique.

Tirosint contains Levothyroxine Sodium.

Tirosint has a total of 2 drug patents out of which 0 drug patents have expired.

Tirosint was authorised for market use on 13 October, 2006.

Tirosint is available in capsule;oral dosage forms.

The generics of Tirosint are possible to be released after 14 March, 2024.

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 13 October, 2006

Treatment: NA


How can I launch a generic of TIROSINT before it's drug patent expiration?
More Information on Dosage

TIROSINT family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic